Singapore markets open in 1 hour 41 minutes
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,249.32 -2,051.71 (-3.09%) CMC Crypto 200
1,380.54 -43.56 (-3.06%)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 397.49M |
| Enterprise value | 397.47M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.49k |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -8.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.47 |
| 52-week change 3 | 390.77% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 49.87 |
| 52-week low 3 | 3.03 |
| 50-day moving average 3 | 35.53 |
| 200-day moving average 3 | 14.54 |
Share statistics
| Avg vol (3-month) 3 | 990.97k |
| Avg vol (10-day) 3 | 267.17k |
| Shares outstanding 5 | 10.51M |
| Implied shares outstanding 6 | 10.51M |
| Float 8 | 6.77M |
| % held by insiders 1 | 0.69% |
| % held by institutions 1 | 56.96% |
| Shares short (28 Mar 2024) 4 | 475.63k |
| Short ratio (28 Mar 2024) 4 | 1.24 |
| Short % of float (28 Mar 2024) 4 | 5.62% |
| Short % of shares outstanding (28 Mar 2024) 4 | 4.53% |
| Shares short (prior month 29 Feb 2024) 4 | 61.06k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 14 Feb 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -59.57% |
| Return on equity (ttm) | -341.98% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -44.44M |
| Net income avi to common (ttm) | -44.6M |
| Diluted EPS (ttm) | -10.31 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 20.91M |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 20.88M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.74 |
| Book value per share (mrq) | -1.56 |
Cash flow statement
| Operating cash flow (ttm) | -36.1M |
| Levered free cash flow (ttm) | -21.24M |
© 2024 Yahoo. All rights reserved.